Useful resources |
Cholinesterase inhibitors for Parkinson's disease dementia (Cochrane Review) ABSTRACT Background: The loss of cholinergic, dopaminergic and noradrenergic innervations seen in Parkinson's Disease Dementia (PDD) suggest a potential role for cholinesterase inhibitors. Concerns have been expressed about a theoretical worsening of Parkinson's disease . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |